Biogened S.A. (WSE:BGD)

Market Cap	65.83M
Revenue (ttm)	110.94M
Net Income (ttm)	4.57M
Shares Out	2.46M
EPS (ttm)	1.86
PE Ratio	14.41
Forward PE	n/a
Dividend	0.50 (1.87%)
Ex-Dividend Date	Sep 12, 2024

Volume	19
Average Volume	60
Open	26.80
Previous Close	n/a
Day's Range	26.80 - 26.80
52-Week Range	16.20 - 32.60
Beta	0.89
RSI	49.16
Earnings Date	May 12, 2025

About Biogened

Biogened S.A. develops, produces, and distributes pharmaceutical products in Poland. The company offers dermo-cosmetics under the Dermedic brand; and thermal water. It also exports its products. The company was incorporated in 2007 and is headquartered in Lódz, Poland.

• Industry: Pharmaceutical Preparations
• Founded: 2007
• Employees: 222
• Stock Exchange: Warsaw Stock Exchange
• Ticker Symbol: BGD

Financial Performance

In 2024, Biogened's revenue was 110.94 million, an increase of 16.09% compared to the previous year's 95.56 million. Earnings were 4.57 million, a decrease of -10.38%.